Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Molecular signaling mechanisms underlying Alzheimer's disease (AD) remain unclear. Maintenance of memory and synaptic plasticity depend on de novo protein synthesis, dysregulation of which is implicated in AD. Recent studies showed AD-associated hyperphosphorylation of mRNA translation factor eukaryotic elongation factor 2 (eEF2), which results in inhibition of protein synthesis. We tested to determine whether suppression of eEF2 phosphorylation could improve protein synthesis capacity and AD-associated cognitive and synaptic impairments. Genetic reduction of the eEF2 kinase (eEF2K) in 2 AD mouse models suppressed AD-associated eEF2 hyperphosphorylation and improved memory deficits and hippocampal long-term potentiation (LTP) impairments without altering brain amyloid β (Aβ) pathology. Furthermore, eEF2K reduction alleviated AD-associated defects in dendritic spine morphology, postsynaptic density formation, de novo protein synthesis, and dendritic polyribosome assembly. Our results link eEF2K/eEF2 signaling dysregulation to AD pathophysiology and therefore offer a feasible therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
The novel object recognition memory: neurobiology, test procedure, and its modifications
Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390
SUnSET, a nonradioactive method to monitor protein synthesis
Schmidt, E. K., Clavarino, G., Ceppi, M., & Pierre, P. (2009) · Nature Methods · doi:10.1038/nmeth.1314 · Cited by 1,706
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006767 · Cited by 589
Research works printed but not linked: 41
- 10.1097/00001756-200104170-00025 · DOI
- 10.1101/lm.033969.113 · DOI
- 10.1016/j.neuron.2008.10.055 · DOI · Paper page
- 10.1016/0169-328X(89)90060-0 · DOI
- 10.1007/s00401-015-1487-z · DOI · Paper page
- 10.1042/BST20140323 · DOI · Paper page
- Ryazanov, 1989, Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation, FEBS Lett, 251, 187, 10.1016/0014-5793(89)81452-8 · DOI · Paper page
- 10.1007/s00401-016-1634-1 · DOI
- 10.1038/nn.3486 · DOI · Paper page
- 10.1038/nprot.2013.155 · DOI · Paper page
- Vogel-Ciernia, 2014, Examining object location and object recognition memory in mice, Curr Protoc Neurosci, 69, 8.31.1, 10.1002/0471142301.ns0831s69 · DOI · Paper page
- Ma, 2012, Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease, J Neurochem, 120 Suppl 1, 140, 10.1111/j.1471-4159.2011.07506.x · DOI · Paper page
- 10.1186/1750-1326-6-63 · DOI · Paper page
- 10.1038/35104061 · DOI · Paper page
- 10.1152/physrev.00012.2013 · DOI · Paper page
- 10.1016/j.cell.2006.09.014 · DOI · Paper page
- 10.1371/journal.pone.0107591 · DOI · Paper page
- 10.1002/hipo.22841 · DOI · Paper page
- 10.1016/j.cmet.2014.09.013 · DOI · Paper page
- 10.1096/fj.10-167361 · DOI · Paper page
- 10.2174/138161207780858401 · DOI
- 10.1089/ars.2007.1764 · DOI · Paper page
- 10.1016/j.cell.2013.04.055 · DOI · Paper page
- 10.1016/j.nlm.2007.08.009 · DOI
- 10.1046/j.1432-1033.2002.03290.x · DOI · Paper page
- 10.1101/lm.027664.112 · DOI · Paper page
- 10.1016/j.nlm.2013.04.013 · DOI · Paper page
- Beckelman, 2016, Impaired eukaryotic elongation factor 1A expression in Alzheimer’s disease, Neurodegener Dis, 16, 39, 10.1159/000438925 · DOI
- 10.3233/JAD-160036 · DOI
- 10.1016/j.nlm.2013.04.015 · DOI · Paper page
- 10.1111/jnc.14306 · DOI
- 10.1523/JNEUROSCI.0119-10.2010 · DOI · Paper page
- 10.1016/j.neuron.2007.07.030 · DOI · Paper page
- Korol’, 2008, Disruption of calcium homeostasis in Alzheimer’s disease, Neurophysiology, 40, 385, 10.1007/s11062-009-9064-5 · DOI
- 10.1016/j.bbrc.2016.09.053 · DOI · Paper page
- 10.1007/s00401-011-0865-4 · DOI · Paper page
- 10.4161/chan.19415 · DOI
- Mackenzie, 2016, Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies, J Neurochem, 138, 54, 10.1111/jnc.13588 · DOI · Paper page
- Garcia-Esparcia, 2017, Dementia with Lewy bodies: molecular pathology in the frontal cortex in typical and rapidly progressive forms, Front Neurol, 8, 10.3389/fneur.2017.00089 · DOI · Paper page
- 10.1212/WNL.41.4.479 · DOI · Paper page
- 10.1016/j.devcel.2014.01.027 · DOI · Paper page
Cited by
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Amyloid Precursor Protein and Alzheimer’s Disease
Orobets, K. S., & Karamyshev, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914794 · Cited by 141
“In AD mouse models, the phosphorylation of eEF2 is enhanced, suggesting the involvement of this elongation factor in AD pathology development [137].”
BackgroundShigemizu, D., Mori, T., Akiyama, S., Higaki, S., Watanabe, H., Sakurai, T., Niida, S., & Ozaki, K. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00654-x · Cited by 103
Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer’s model mice
Zimmermann, H. R., Yang, W., Kasica, N. P., Zhou, X., Wang, X., Beckelman, B. C., Lee, J., Furdui, C. M., Keene, C. D., & Ma, T. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133982 · Cited by 86
“Consistent with a previous study(28), overall dendritic spine density in Tg mice was significantly decreased as compared with that in WT controls (Figure 4B).”
BackgroundMethodResultInfluentialSelf-citationMa, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15541 · Cited by 55
Self-citation
Metadata
- Authors
- Beckelman, B. C., Yang, W., Kasica, N. P., Zimmermann, H. R., Zhou, X., Keene, C. D., Ryazanov, A. G., & Ma, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2019-01-22
- Volume
- 129
- Issue
- 2
- Pages
- 820-833
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2911277088
- Cited by
- 113
- References
- 22
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- National Institute on Aging (R01 AG055581,R01 AG056622,R00 AG044469)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice. https://app.cochat.ai/papers/10.1172/jci122954
- The paper
- Beckelman, B. C., Yang, W., Kasica, N. P., Zimmermann, H. R., Zhou, X., Keene, C. D., Ryazanov, A. G., & Ma, T. (2019). Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer’s disease model mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci122954
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.